LLMpediaThe first transparent, open encyclopedia generated by LLMs

Michael Good

⚠Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Michael J. Massimino Hop 5 terminal

This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.

Michael Good
NameMichael Good
OccupationPhysician, epidemiologist, academic
Known forResearch on infectious diseases, vaccine policy, outbreak response

Michael Good

Michael Good is an American physician and infectious disease epidemiologist noted for his work on vaccine-preventable diseases, outbreak investigation, and public health policy. He has held academic appointments, led laboratory and clinical research programs, and served on advisory panels that influenced national and international responses to emerging infections. His career spans clinical practice, translational research, and public health leadership across universities, federal agencies, and professional societies.

Early life and education

Good was born and raised in the United States and trained in medicine and infectious diseases at leading institutions. He earned his medical degree and completed residency training at institutions affiliated with Johns Hopkins Hospital, Massachusetts General Hospital, and Mayo Clinic-level teaching programs. His postgraduate fellowship combined clinical infectious disease training with research at centers linked to Centers for Disease Control and Prevention collaborations and academic departments associated with Harvard Medical School and University of Pennsylvania Health System. During this period he developed expertise in clinical microbiology, immunology, and vaccine development working with investigators from National Institutes of Health, World Health Organization, and regional public health laboratories.

Academic and research career

Good’s academic appointments have included faculty positions at major research universities and leadership of translational laboratories connected to medical centers and public health schools. He has directed research programs encompassing clinical trials, pathogen surveillance, and laboratory-based studies in collaboration with investigators at Yale School of Medicine, University of Michigan, University of California, San Francisco, and other research-intensive institutions. His laboratory collaborations extended to national research networks funded by National Institute of Allergy and Infectious Diseases and consortia linked to Biomedical Advanced Research and Development Authority initiatives. He served as principal investigator on grants from National Institutes of Health and cooperative agreements involving partnerships with Centers for Disease Control and Prevention teams and state health departments, producing peer-reviewed work in journals connected to American Society for Microbiology and specialty societies such as Infectious Diseases Society of America.

Contributions to infectious disease epidemiology

Good’s contributions span pathogen-specific epidemiology, vaccine impact assessment, and outbreak analytics. He published studies on transmission dynamics of respiratory and enteric pathogens that informed policy discussions at agencies including Food and Drug Administration and European Centre for Disease Prevention and Control. His trial work evaluated vaccine efficacy and immunogenicity in collaboration with industrial partners and academic vaccinology groups affiliated with Gavi, the Vaccine Alliance, Bill & Melinda Gates Foundation-funded programs, and manufacturer-sponsored consortia. He collaborated on surveillance methodologies that integrated data from state health departments and electronic health records linked to networks such as Healthcare Cost and Utilization Project and national laboratory systems coordinated by Association of Public Health Laboratories. His modeling and field investigations intersected with teams at Imperial College London, London School of Hygiene & Tropical Medicine, and University of Oxford during international outbreak responses.

Public health leadership and advisory roles

Good has provided advisory input to federal and international organizations during epidemic and pandemic planning. He served on advisory committees advising Centers for Disease Control and Prevention, participated in guideline development for World Health Organization working groups, and contributed to expert panels convened by National Academies of Sciences, Engineering, and Medicine. He held leadership roles in professional organizations including Infectious Diseases Society of America sections and committees of American Public Health Association. Good advised state health departments and hospital systems during responses coordinated with Federal Emergency Management Agency and regional health coalitions, and he taught outbreak response courses alongside faculty from Johns Hopkins Bloomberg School of Public Health and Columbia University Mailman School of Public Health.

Awards and honors

Good’s work has been recognized with awards and honors from academic institutions, professional societies, and public health organizations. He received accolades from entities such as American College of Physicians, Infectious Diseases Society of America, and university research offices for excellence in clinical investigation and public service. He was invited as a visiting lecturer at schools including Harvard T.H. Chan School of Public Health, Stanford University School of Medicine, and Yale School of Public Health, and he held named research awards and competitive grant honors from National Institutes of Health study sections and philanthropic funders.

Personal life and legacy

Outside of his professional roles, Good has engaged in mentoring trainees, contributing to capacity building for clinicians and epidemiologists in domestic and international settings. His mentees have taken positions across academia, public health agencies, and industry at organizations like Pfizer, Moderna, and national public health institutes. His legacy includes methodological advances in outbreak investigation, published guidance used by practitioners at Centers for Disease Control and Prevention and World Health Organization, and a cohort of leaders in infectious disease epidemiology who continue collaborative work in vaccine science and pandemic preparedness.

Category:American epidemiologists Category:Infectious disease physicians